摘要
BACKGROUND The coronavirus disease 2019(COVID-19)outbreak has markedly influenced the endoscopic patterns.Endoscopic retrograde cholangiopancreatography(ERCP)is an essential technique for pancreatobiliary disease but increases the risk of exposure to the virus-containing body fluid;however,the impact of COVID-19 on ERCP is unknown.AIM To compare the number of endoscopic activities and to analyze the clinical outcomes of ERCPs before and during the COVID-19 outbreak in Daegu,South Kore.METHODS This retrospective cohort study included patients aged≥18 years who underwent ERCP between February 18 and March 28,2020,at a tertiary hospital.ERCP indications and endoscopic details were compared with those from the same period in 2018 and 2019 as control groups.RESULTS Of the 269 ERCP procedures,113(42.0%)cases were performed as emergency procedures.The number of ERCP procedures in 2018 and 2019 decreased by 20.2%and 56.6%,respectively,compared with that in 2020(P<0.01);among the 113 emergency ERCPs,the observed numbers in 2018(n=42)and 2019(n=55)dramatically dropped by 61.9%and 70.9%,respectively,compared with that in 2020(n=16).Of the 16 cases in 2020,stone removal was performed in five,biliary stenting in five,sphincterotomy in five,and nasobiliary drainage in one.No case of ERCP-related infection in medical workers or other patients has been reported.CONCLUSION The COVID-19 outbreak significantly reduced the number of ERCPs;however,there is no difference in the indications and endoscopic interventions before and during the COVID-19 outbreak.
